Report Detail
Global Cardiac-on-a-Chip Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4748774 |
- 05 October, 2026 |
- Global |
- 113 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Cardiac-on-a-Chip market size was valued at US$ 1324 million in 2025 and is forecast to a readjusted size of US$ 4688 million by 2032 with a CAGR of 20.0% during review period.
Cardiac-on-a-Chip is a biosimulation technology designed to simulate the structure and function of the human heart. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured cardiomyocytes are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of a real heart, such as myocardial contraction, cardiac electrical activity, etc.
Heart-on-a-chip can be used to simulate cardiac physiology, study the pathogenesis of heart disease, evaluate the efficacy and toxicity of drugs, and develop new treatments for heart disease. This technology provides a highly controllable and reproducible experimental platform for heart-related research, helps understand cardiac physiology and pathology, and accelerates the diagnosis and treatment of heart diseases.
As an emerging market segment in the biomedical field, the cardiac chip market has received widespread attention in recent years. As the global population ages, the prevalence of heart disease increases year by year, which provides a broad space for development of the cardiac chip market. As an innovative medical technology and tool, the market size of cardiac chips is constantly expanding. Cardiac chips have wide applications in many fields, including diagnosis of heart disease, drug screening, toxicity testing, and personalized medicine. By simulating the structure and function of heart tissue, the heart chip can provide a more accurate and efficient experimental platform and promote the research and treatment of heart diseases. Overall, the cardiac chip market has broad development prospects and huge market potential.
This report is a detailed and comprehensive analysis for global Cardiac-on-a-Chip market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cardiac-on-a-Chip market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Cardiac-on-a-Chip market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Cardiac-on-a-Chip market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Cardiac-on-a-Chip market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cardiac-on-a-Chip
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cardiac-on-a-Chip market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emulate, CN Bio, TissUse, Axion Biosystems, Nortis, InSphero, Mimetas, Ascendance Biotechnology, Tara Biosystems, BioIVT, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cardiac-on-a-Chip market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Myocardial Chip
Heart Tissue Chip
Cardiovascular Chip
Market segment by Application
Pharmaceutical R&D
Cardiovascular Disease Research
Clinical Diagnosis
Major players covered
Emulate
CN Bio
TissUse
Axion Biosystems
Nortis
InSphero
Mimetas
Ascendance Biotechnology
Tara Biosystems
BioIVT
Hesperos
Zhejiang Ruiao Biotechnology
BGI Genomics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cardiac-on-a-Chip product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cardiac-on-a-Chip, with price, sales quantity, revenue, and global market share of Cardiac-on-a-Chip from 2021 to 2026.
Chapter 3, the Cardiac-on-a-Chip competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiac-on-a-Chip breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cardiac-on-a-Chip market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiac-on-a-Chip.
Chapter 14 and 15, to describe Cardiac-on-a-Chip sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Cardiac-on-a-Chip Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Myocardial Chip
- 1.3.3 Heart Tissue Chip
- 1.3.4 Cardiovascular Chip
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Cardiac-on-a-Chip Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Pharmaceutical R&D
- 1.4.3 Cardiovascular Disease Research
- 1.4.4 Clinical Diagnosis
- 1.5 Global Cardiac-on-a-Chip Market Size & Forecast
- 1.5.1 Global Cardiac-on-a-Chip Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Cardiac-on-a-Chip Sales Quantity (2021-2032)
- 1.5.3 Global Cardiac-on-a-Chip Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Emulate
- 2.1.1 Emulate Details
- 2.1.2 Emulate Major Business
- 2.1.3 Emulate Cardiac-on-a-Chip Product and Services
- 2.1.4 Emulate Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Emulate Recent Developments/Updates
- 2.2 CN Bio
- 2.2.1 CN Bio Details
- 2.2.2 CN Bio Major Business
- 2.2.3 CN Bio Cardiac-on-a-Chip Product and Services
- 2.2.4 CN Bio Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 CN Bio Recent Developments/Updates
- 2.3 TissUse
- 2.3.1 TissUse Details
- 2.3.2 TissUse Major Business
- 2.3.3 TissUse Cardiac-on-a-Chip Product and Services
- 2.3.4 TissUse Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 TissUse Recent Developments/Updates
- 2.4 Axion Biosystems
- 2.4.1 Axion Biosystems Details
- 2.4.2 Axion Biosystems Major Business
- 2.4.3 Axion Biosystems Cardiac-on-a-Chip Product and Services
- 2.4.4 Axion Biosystems Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Axion Biosystems Recent Developments/Updates
- 2.5 Nortis
- 2.5.1 Nortis Details
- 2.5.2 Nortis Major Business
- 2.5.3 Nortis Cardiac-on-a-Chip Product and Services
- 2.5.4 Nortis Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Nortis Recent Developments/Updates
- 2.6 InSphero
- 2.6.1 InSphero Details
- 2.6.2 InSphero Major Business
- 2.6.3 InSphero Cardiac-on-a-Chip Product and Services
- 2.6.4 InSphero Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 InSphero Recent Developments/Updates
- 2.7 Mimetas
- 2.7.1 Mimetas Details
- 2.7.2 Mimetas Major Business
- 2.7.3 Mimetas Cardiac-on-a-Chip Product and Services
- 2.7.4 Mimetas Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Mimetas Recent Developments/Updates
- 2.8 Ascendance Biotechnology
- 2.8.1 Ascendance Biotechnology Details
- 2.8.2 Ascendance Biotechnology Major Business
- 2.8.3 Ascendance Biotechnology Cardiac-on-a-Chip Product and Services
- 2.8.4 Ascendance Biotechnology Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Ascendance Biotechnology Recent Developments/Updates
- 2.9 Tara Biosystems
- 2.9.1 Tara Biosystems Details
- 2.9.2 Tara Biosystems Major Business
- 2.9.3 Tara Biosystems Cardiac-on-a-Chip Product and Services
- 2.9.4 Tara Biosystems Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Tara Biosystems Recent Developments/Updates
- 2.10 BioIVT
- 2.10.1 BioIVT Details
- 2.10.2 BioIVT Major Business
- 2.10.3 BioIVT Cardiac-on-a-Chip Product and Services
- 2.10.4 BioIVT Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 BioIVT Recent Developments/Updates
- 2.11 Hesperos
- 2.11.1 Hesperos Details
- 2.11.2 Hesperos Major Business
- 2.11.3 Hesperos Cardiac-on-a-Chip Product and Services
- 2.11.4 Hesperos Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Hesperos Recent Developments/Updates
- 2.12 Zhejiang Ruiao Biotechnology
- 2.12.1 Zhejiang Ruiao Biotechnology Details
- 2.12.2 Zhejiang Ruiao Biotechnology Major Business
- 2.12.3 Zhejiang Ruiao Biotechnology Cardiac-on-a-Chip Product and Services
- 2.12.4 Zhejiang Ruiao Biotechnology Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Zhejiang Ruiao Biotechnology Recent Developments/Updates
- 2.13 BGI Genomics
- 2.13.1 BGI Genomics Details
- 2.13.2 BGI Genomics Major Business
- 2.13.3 BGI Genomics Cardiac-on-a-Chip Product and Services
- 2.13.4 BGI Genomics Cardiac-on-a-Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 BGI Genomics Recent Developments/Updates
3 Competitive Environment: Cardiac-on-a-Chip by Manufacturer
- 3.1 Global Cardiac-on-a-Chip Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Cardiac-on-a-Chip Revenue by Manufacturer (2021-2026)
- 3.3 Global Cardiac-on-a-Chip Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Cardiac-on-a-Chip by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Cardiac-on-a-Chip Manufacturer Market Share in 2025
- 3.4.3 Top 6 Cardiac-on-a-Chip Manufacturer Market Share in 2025
- 3.5 Cardiac-on-a-Chip Market: Overall Company Footprint Analysis
- 3.5.1 Cardiac-on-a-Chip Market: Region Footprint
- 3.5.2 Cardiac-on-a-Chip Market: Company Product Type Footprint
- 3.5.3 Cardiac-on-a-Chip Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Cardiac-on-a-Chip Market Size by Region
- 4.1.1 Global Cardiac-on-a-Chip Sales Quantity by Region (2021-2032)
- 4.1.2 Global Cardiac-on-a-Chip Consumption Value by Region (2021-2032)
- 4.1.3 Global Cardiac-on-a-Chip Average Price by Region (2021-2032)
- 4.2 North America Cardiac-on-a-Chip Consumption Value (2021-2032)
- 4.3 Europe Cardiac-on-a-Chip Consumption Value (2021-2032)
- 4.4 Asia-Pacific Cardiac-on-a-Chip Consumption Value (2021-2032)
- 4.5 South America Cardiac-on-a-Chip Consumption Value (2021-2032)
- 4.6 Middle East & Africa Cardiac-on-a-Chip Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Cardiac-on-a-Chip Sales Quantity by Type (2021-2032)
- 5.2 Global Cardiac-on-a-Chip Consumption Value by Type (2021-2032)
- 5.3 Global Cardiac-on-a-Chip Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Cardiac-on-a-Chip Sales Quantity by Application (2021-2032)
- 6.2 Global Cardiac-on-a-Chip Consumption Value by Application (2021-2032)
- 6.3 Global Cardiac-on-a-Chip Average Price by Application (2021-2032)
7 North America
- 7.1 North America Cardiac-on-a-Chip Sales Quantity by Type (2021-2032)
- 7.2 North America Cardiac-on-a-Chip Sales Quantity by Application (2021-2032)
- 7.3 North America Cardiac-on-a-Chip Market Size by Country
- 7.3.1 North America Cardiac-on-a-Chip Sales Quantity by Country (2021-2032)
- 7.3.2 North America Cardiac-on-a-Chip Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Cardiac-on-a-Chip Sales Quantity by Type (2021-2032)
- 8.2 Europe Cardiac-on-a-Chip Sales Quantity by Application (2021-2032)
- 8.3 Europe Cardiac-on-a-Chip Market Size by Country
- 8.3.1 Europe Cardiac-on-a-Chip Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Cardiac-on-a-Chip Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cardiac-on-a-Chip Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Cardiac-on-a-Chip Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Cardiac-on-a-Chip Market Size by Region
- 9.3.1 Asia-Pacific Cardiac-on-a-Chip Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Cardiac-on-a-Chip Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Cardiac-on-a-Chip Sales Quantity by Type (2021-2032)
- 10.2 South America Cardiac-on-a-Chip Sales Quantity by Application (2021-2032)
- 10.3 South America Cardiac-on-a-Chip Market Size by Country
- 10.3.1 South America Cardiac-on-a-Chip Sales Quantity by Country (2021-2032)
- 10.3.2 South America Cardiac-on-a-Chip Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cardiac-on-a-Chip Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Cardiac-on-a-Chip Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Cardiac-on-a-Chip Market Size by Country
- 11.3.1 Middle East & Africa Cardiac-on-a-Chip Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Cardiac-on-a-Chip Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Cardiac-on-a-Chip Market Drivers
- 12.2 Cardiac-on-a-Chip Market Restraints
- 12.3 Cardiac-on-a-Chip Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Cardiac-on-a-Chip and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Cardiac-on-a-Chip
- 13.3 Cardiac-on-a-Chip Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Cardiac-on-a-Chip Typical Distributors
- 14.3 Cardiac-on-a-Chip Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Cardiac-on-a-Chip. Industry analysis & Market Report on Cardiac-on-a-Chip is a syndicated market report, published as Global Cardiac-on-a-Chip Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Cardiac-on-a-Chip market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
